Background and aim Narcolepsy is an uncommon hypothalamic disorder of presumed
autoimmune origin that usually requires lifelong treatment. This paper aims to provide …

This article addresses the clinical presentation, diagnosis, pathophysiology and
management of narcolepsy type 1 and 2, with a focus on recent findings. A low level of …

Abstract Narcolepsy type 1 (NT1) and type 2 (NT2), also known as narcolepsy with and
without cataplexy, are sleep disorders that benefited from major scientific advances over the …

Background Whether depression and suicide thoughts relate to restless legs syndrome
(RLS) or comorbidities associated with RLS remain unclear. Objectives To determine …

Patients with narcolepsy live with a lifelong sleep-wake disorder, impairing their quality of
life, productivity, educational and employment outcomes. Clinicians are becoming aware …

Abstract Study Objectives To describe the phenotype of narcolepsy with intermediate
cerebrospinal fluid hypocretin-1 levels (CSF hcrt-1). Methods From 1600 consecutive …

Abstract Study Objectives Despite its high frequency in narcolepsy type 1 (NT1), disrupted
nocturnal sleep (DNS) remains understudied, and its determinants have been poorly …

Background and Objectives To explore the first coronavirus disease 2019 (COVID-19)
lockdown effect on sleep symptoms in patients with narcolepsy, idiopathic hypersomnia (IH) …

Background Patients with dyslipidemia are at increased risk for suicide, especially those
with major depressive disorder (MDD). Few studies have investigated the independent …

We analysed the co‐existence of psychopathology in patients with narcolepsy at our centre.
We performed an observational retrospective descriptive analysis of patients with a …